188 related articles for article (PubMed ID: 28801349)
1. C-myc expression in adrenocortical tumours.
Pennanen M; Hagström J; Heiskanen I; Sane T; Mustonen H; Arola J; Haglund C
J Clin Pathol; 2018 Feb; 71(2):129-134. PubMed ID: 28801349
[TBL] [Abstract][Full Text] [Related]
2. Expression and significance of Wnt signaling components and their target genes in breast carcinoma.
He Y; Liu Z; Qiao C; Xu M; Yu J; Li G
Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141
[TBL] [Abstract][Full Text] [Related]
3. [Expression and significance of APC, beta-catenin, C-myc, and Cyclin D1 proteins in colorectal carcinoma].
Dai WB; Ren ZP; Chen WL; DU J; Shi Z; Tang DY
Ai Zheng; 2007 Sep; 26(9):963-6. PubMed ID: 17927853
[TBL] [Abstract][Full Text] [Related]
4. Low SGK1 expression in human adrenocortical tumors is associated with ACTH-independent glucocorticoid secretion and poor prognosis.
Ronchi CL; Sbiera S; Leich E; Tissier F; Steinhauer S; Deutschbein T; Fassnacht M; Allolio B
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2251-60. PubMed ID: 23055545
[TBL] [Abstract][Full Text] [Related]
5. Expression and clinical significance of Wnt players and survivin in pituitary tumours.
Formosa R; Gruppetta M; Falzon S; Santillo G; DeGaetano J; Xuereb-Anastasi A; Vassallo J
Endocr Pathol; 2012 Jun; 23(2):123-31. PubMed ID: 22327960
[TBL] [Abstract][Full Text] [Related]
6. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis.
Nosho K; Yamamoto H; Mikami M; Taniguchi H; Takahashi T; Adachi Y; Imamura A; Imai K; Shinomura Y
Eur J Cancer; 2006 Sep; 42(14):2374-81. PubMed ID: 16809031
[TBL] [Abstract][Full Text] [Related]
8. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.
Nakazumi H; Sasano H; Iino K; Ohashi Y; Orikasa S
Mod Pathol; 1998 Dec; 11(12):1165-70. PubMed ID: 9872646
[TBL] [Abstract][Full Text] [Related]
9. Discerning malignancy in human adrenocortical neoplasms: utility of DNA flow cytometry and immunohistochemistry.
Suzuki T; Sasano H; Nisikawa T; Rhame J; Wilkinson DS; Nagura H
Mod Pathol; 1992 May; 5(3):224-31. PubMed ID: 1353877
[TBL] [Abstract][Full Text] [Related]
10. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
11. Expression of non-membranous beta-catenin and gamma-catenin, c-Myc and cyclin D1 in relation to patient outcome in human colon adenocarcinomas.
Bondi J; Bukholm G; Nesland JM; Bukholm IR
APMIS; 2004 Jan; 112(1):49-56. PubMed ID: 14961975
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between the expression of beta-cat, cyclin D1 and c-myc and the occurance and biological behavior of pancreatic cancer].
Li YJ; Ji XR
Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):238-41. PubMed ID: 12882690
[TBL] [Abstract][Full Text] [Related]
13. A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1.
Cheah PY; Choo PH; Yao J; Eu KW; Seow-Choen F
Cancer; 2002 Dec; 95(12):2479-86. PubMed ID: 12467060
[TBL] [Abstract][Full Text] [Related]
14. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of β-catenin, c-myc, and cyclin D1 expressions in patients with esophageal squamous cell carcinoma.
Wang W; Xue L; Wang P
Med Oncol; 2011 Mar; 28(1):163-9. PubMed ID: 20143187
[TBL] [Abstract][Full Text] [Related]
16. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
17. The prognostic impact of hormone receptors and c-erbB-2 in pregnancy-associated breast cancer and their correlation with BRCA1 and cell cycle modulators.
Reed W; Sandstad B; Holm R; Nesland JM
Int J Surg Pathol; 2003 Apr; 11(2):65-74. PubMed ID: 12754622
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of beta-catenin, E-cadherin, cyclin D1 and c-myc in benign trichogenic tumors.
Demirkan NC; Bir F; Erdem O; Düzcan E
J Cutan Pathol; 2007 Jun; 34(6):467-73. PubMed ID: 17518774
[TBL] [Abstract][Full Text] [Related]
20. Nuclear DNA content and morphological characteristics in the prognosis of adrenocortical carcinoma.
Haak HR; Cornelisse CJ; Hermans J; Cobben L; Fleuren GJ
Br J Cancer; 1993 Jul; 68(1):151-5. PubMed ID: 8318407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
